XML 17 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2024   77,450,794      
Balance beginning of period at Dec. 31, 2024 $ 1,760,005 $ 77 $ 5,730,367 $ (3,984,865) $ 14,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,792     6,792  
Unrealized gain (loss) on derivatives (1,586)       (1,586)
Reclassification to interest expense, net (2,242)       (2,242)
Distributions declared (18,438)     (18,438)  
Stock-based compensation, net (in shares)   116,970      
Stock-based compensation, net 275 $ 1 274    
Balance end of period (in shares) at Mar. 31, 2025   77,567,764      
Balance end of period at Mar. 31, 2025 $ 1,744,806 $ 78 5,730,641 (3,996,511) 10,598
Balance beginning of period (in shares) at Dec. 31, 2025 77,691,533 77,691,533      
Balance beginning of period at Dec. 31, 2025 $ 1,794,262 $ 78 5,736,652 (3,947,229) 4,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 5,184     5,184  
Unrealized gain (loss) on derivatives 2,838       2,838
Reclassification to interest expense, net (1,606)       (1,606)
Distributions declared (19,484)     (19,484)  
Stock-based compensation, net (in shares)   244,324      
Stock-based compensation, net $ (3,112)   (3,112)    
Balance end of period (in shares) at Mar. 31, 2026 77,935,857 77,935,857      
Balance end of period at Mar. 31, 2026 $ 1,778,082 $ 78 $ 5,733,540 $ (3,961,529) $ 5,993